Jennifer Callahan
Director Financiero/CFO en CINGULATE INC. .
Fortuna: 1 635 $ al 31/05/2024
Perfil
Jennifer L.
Callahan is currently working as a Controller at Cingulate Works, Inc. She also holds the position of Secretary, SVP, CFO & CAO at Cingulate, Inc. since 2017.
Ms. Callahan completed her undergraduate degree at Creighton University.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
CINGULATE, INC.
0.04% | 15/03/2024 | 2 333 ( 0.04% ) | 1 635 $ | 31/05/2024 |
Cargos activos de Jennifer Callahan
| Empresas | Cargo | Inicio |
|---|---|---|
| CINGULATE INC. | Director Financiero/CFO | 29/01/2024 |
Cingulate Works, Inc.
 Cingulate Works, Inc. Pharmaceuticals: MajorHealth Technology Cingulate Works, Inc. is a clinical stage biopharmaceutical company which operates drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products. Its products designed to improve the lives of patients suffering from burdensome daily dosing regimens and suboptimal treatment outcomes. The company was founded by Shane J. Schaffer, Matthew N. Brams, Raul R. Silva & Craig Steven Gilgallon in 2013 and is headquartered in Kansas City, KS. | Comptroller/Controller/Auditor | - |
Formación de Jennifer Callahan.
| Creighton University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| CINGULATE INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Cingulate Works, Inc.
Cingulate Works, Inc. Pharmaceuticals: MajorHealth Technology Cingulate Works, Inc. is a clinical stage biopharmaceutical company which operates drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products. Its products designed to improve the lives of patients suffering from burdensome daily dosing regimens and suboptimal treatment outcomes. The company was founded by Shane J. Schaffer, Matthew N. Brams, Raul R. Silva & Craig Steven Gilgallon in 2013 and is headquartered in Kansas City, KS. | Health Technology |
- Bolsa de valores
- Insiders
- Jennifer Callahan
